ABOUT SITUS JUDI MBL77

Not all clients with CLL need therapy. Regardless of all latest advancements, the iwCLL nevertheless recommends watchful observation for clients with asymptomatic sickness.86 This suggestion relies on not less than two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).1